Member Info for Richob

131p so we start 9p down in the morning allegedly.

Just been listening to the parliamentary debate on the lockdown measures and would have loved to have been able to ask some questions.

The government is understandably pinning its hopes on vaccines but has altered the dosage regime for them against the advice of the vaccine producers who remain adamant that three weeks between doses is what is required.

So, in about three weeks time, when some people who have had the first dose catch covid, the likelihood is that a new variant will be blamed rather than the dosage instructions not being followed.

Seems a bit like antibiotics where two tablets a day for seven days does not mean one tablet a day for fourteen days.

If we are to have this dosage change then testing in the increased period between them seems a sensible way of proving that it works rather than just trying to give more people one dose without knowing.

On a different note, they have been paying up to the sp for sells today, so we may well see some larger delayed buys.

All the best.

This update contains so much bull but the journalists can't see it.

Examples:

We are concentrating on the elderly for the vaccine as this is where most covid deaths occur.
FACT 75% of all deaths are in the over 75s every year, virus or no virus.

By extending the dosage gap we will gain more than 50% protection.
FACT Pfizer say don't do this and it is their vaccine.

Just hoping at least one journalist can get to the real points here but looking unlikely.

Give me strength.

Good reminder gmcc.

https://avacta.com/therapeutics/pipeline/

Plenty of non covid opportunities to go with the lfts, therapy and sewage covid plays.

All the best.

https://www.brusselstimes.com/belgium/148172/no-evidence-pfizer-biontech-vaccine-protects-without-timely-second-injection-covid-19-maximum-protection-pierre-van-damme/

Apparently he is on with two scientists, so vaccines are a certainty but perhaps testing might get a push given Prof Hayward's radio 4 interview today.

I think anybody with a mental age of twelve can see the link between vaccination and testing but not many of our beloved leaders appear to have reached that level.

All the best.

Blue skies have begun to increase as the trader winds diminish.

Red dot flashes (from the sun) could occur and investors are warned to be ready for these as weather experts are not sure what they might contain.

The forecast is for continued blue skies with the occasional splash of rain.

Cave Exigo

We need to learn from the new insights and the new technologies, we need to learn from the last lockdown.
"This time round we really have to use this lockdown to bear down on the virus in a way that can protect key workers", he added.

In order to protect key workers, Prof Hayward suggested that employers could be using lateral flow tests for regular testing.

These tests return a positive or negative result witin thirty minutes and Prof Hayward said these should be used for all key workers in order to reduce infection rates in these groups.

The last national lockdown was for four weeks in November, with the first starting in March and lasting through the spring.

Great spot Agent B.

That's SAGE recommending LFTs then Agent B.

Sounds good to me.

All the best.

The weather team relaxed this morning with croissants and sweet black coffee from the MB delivery service before sitting down to watch the warm blue sky that drifted in off an unexpected twitter wind.
Aside of the occasional sell cloud from the usual trader winds a nice day is forecast with a probable formal uplift later when the ODX and Avacta isobars meet to create a strong warm uplift.

This really is nice coffee.

All the best.

Cave Exigo

Boris is on at 8pm as Scotland have gone for full lockdown until the end of January, so it looks like England is to follow.

No doubt he will mention vaccines and with a little push testing as well.

Would love to be one of the journalists !

All the best.

I think there are 195 countries in the world.

A "nice to have" UK order is one thing but a "world order" is surely something else?

All the best.

Looks like AVA04 is another one.

https://drug-dev.com/avactas-proprietary-tmac-cancer-therapy-platform-demonstrates-successful-proof-of-concept/

All the best.

Unfortunately it isn't going away.

Time somebody brought out a therapy.

Come on Affyxell.

All the best.

Whilst it would be great to help the UK out of what appears to be an ever increasing hole, Avacta has the whole world to go at.

If the UK government talk about (hundreds of) millions of tests then the world is talking billions.

Other aspects of the ever changing approaches given the variants and some doubts that the current vaccines will be less effective include an increased likelihood that a therapy or therapies will be sought and we know that Affyxell are working on this aspect.

As has been rightly pointed out in the AVA6000 thread, this is a world beating opportunity on its own.

High S&S numbers would set this alight for a company with an sp of 23p just eight months ago.

Looking forward to the next couple of weeks.

All the best.

In addition to AVA6000 there are quite a few others:

https://avacta.com/therapeutics/pipeline/

Pretty good in my humble opinion.

All the best.

I think we will see S&S figures first and that could be as early as this week.

I think Finn Cap mentioned the data being what would be released first.

Or you could just put the vaccine in the beer and have as many doses as you wanted.

The extended partnership with Daewoong has the potential for a therapy.

https://avacta.com/expansion-of-partnership-with-daewoong-pharmaceutical-to-include-covid-19-neutralising-affimer-therapy/

Given that the vaccines don't stop you catching covid and only last for a limited timeframe, this seems a logical route to market.

Daewoong appear to be looking at a number of potential therapies, some of which may not involve us but the RNS does indicate an involvement from Avacta.

Clearly this is additional to BAMS and LFTs (plural).

There is also a few slides on the Avacta website about how affimers improve stem cell therapies.

All the best.

We have had many ups and downs here and at times it has been hard to hold and add but that is what I have done.

I might have made money trading but my approach to buying a share is purely based on my own research and I am not a pot luck trader (no problem if you are).

The last few days have made me so much more confident of making the right choice here. In no particular order, here are the reasons:

1. The CTA filing for AVA6000. This is a major milestone for Avacta and it's technology.
2. The desire on the covid front to only produce the most effective outcomes (BAMS, LFTs, ELISA).
3. The obvious issues with the vaccines, particularly the recent changes to dosage timescales which are apposite to the statements by the companies that have manufactured the vaccines.
4. The government indemnifying itself and the pharmaceutical companies against vaccine problems.
5. The likelihood that a therapy will be required and our link in that respect to Daewoong.
6. The increased understanding that governments, including our own, have spent fortunes on inadequate resolutions.
7. Nowhere in the world has resolved the covid problems and the numbers are clearly increasing worldwide (the biggest market there is).
8. Covid aside, the pipeline of therapeutics here is massive.

I won't go on (U could) but I do think that 2021 is the massive year for Avacta.

All the best. Treat and test.